
Reset all filters
01 2Terlivaz
Main Therapeutic Indication : Nephrology
Currency : USD
2023 Revenue in Millions : 16
2022 Revenue in Millions : 1
Growth (%) : 1,200
Main Therapeutic Indication : Nephrology
Currency : USD
2024 Revenue in Millions : 25
2023 Revenue in Millions : 16
Growth (%) : 58